平衡易位携带者中亲本来源对获得整倍体胚胎的影响及预测因素
回顾性分析123对平衡易位携带者夫妇的179个PGT-SR周期和614个囊胚,比较雌雄携带者的结局。结果显示亲本来源不影响卵巢刺激参数或PGT-SR结局,可活检囊胚数是获得至少一个整倍体胚胎的显著预测因素(调整OR 1.752;95%CI 1.359-2.259;P<0.001)。结论认为年轻平衡易位携带者的亲本来源不影响PGT-SR结局,获得一个整倍体胚胎至少需要3.5个囊胚。
要点
- 雌性携带者与男性携带者的获卵数、囊胚率、活检取消率、可活检囊胚数及整倍体比例均无显著差异。
- 可活检囊胚数与获得至少一个整倍体胚胎的几率显著相关(调整OR 1.752;95%CI 1.359-2.259;P<0.001)。
- 以3.5为阈值计算获得至少一个整倍体胚胎所需可活检囊胚数,少于4个囊胚时获得整倍体胚胎的概率低。
核心结论
- 亲本来源不影响年轻平衡易位携带者的PGT-SR结局。
- 获得至少一个整倍体胚胎需要至少3.5个囊胚。
- 当一个PGT周期获得少于4个囊胚时,获得一个整倍体胚胎的概率低,应告知夫妇。
研究设计与样本
- 回顾性分析123对携带平衡易位夫妇的179个PGT-SR周期和614个囊胚。
- 滋养层活检后行下一代测序(NGS)。
主要发现
- 雌性携带者与男性携带者的获卵数分别为11.95 ± 5.71与11.82 ± 6.26,无差异。
- 雌性携带者与男性携带者的囊胚率分别为0.42 ± 0.27与0.45 ± 0.28,无差异。
- 雌性携带者与男性携带者的活检取消率分别为11.7%与12.9%,无差异。
- 雌性携带者与男性携带者的可活检囊胚数分别为3.70 ± 2.58与4.04 ± 3.51,无差异。
- 雌性携带者与男性携带者的整倍体胚胎比例分别为23.80%与25.42%、非整倍体胚胎比例分别为58.10%与57.52%、嵌合体胚胎比例分别为18.10%与17.06%,均无差异。
关键数值与推荐
- 多因素logistic回归模型中,可活检囊胚数与获得至少一个整倍体胚胎的几率显著相关(调整OR 1.752;95%CI 1.359-2.259;P<0.001)。
- 受试者工作特征分析采用3.5为阈值计算获得至少一个整倍体胚胎所需可活检囊胚数。
临床怎么用
- 应告知夫妇:当一个PGT周期获得少于4个囊胚时,获得一个整倍体胚胎的概率低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What is the effect of parental origin of translocation and predictors for obtaining a euploid embryo in preimplantation genetic testing for chromosomal structural rearrangements (PGT-SR) for balanced translocation carriers? DESIGN: A total of 179 PGT-SR cycles and 614 blastocysts from 123 couples carrying a balanced translocation were retrospectively analysed. Next-generation sequencing (NGS) was performed after trophectoderm biopsy. RESULTS: There were no differences in ovarian stimulation parameters or PGT-SR outcomes regarding the number of oocytes retrieved (11.95 ± 5.71 versus 11.82 ± 6.26), blastulation rate (0.42 ± 0.27 versus 0.45 ± 0.28), biopsy cancellation rate (11.7% versus 12.9%), the number of blastocysts for biopsy (3.70 ± 2.58 versus 4.04 ± 3.51), or the proportion of euploid embryos (23.80% versus 25.42%), aneuploid embryos (58.10% versus 57.52%) and mosaic embryos (18.10% versus 17.06%) between female carriers and male partner carriers. In a multivariate logistic regression model, the number of blastocysts for biopsy (adjusted odds ratio 1.752; 95% confidence interval 1.359-2.259; P < 0.001) was significantly associated with the chance of obtaining at least one euploid embryo. Receiver operating characteristic analysis with a threshold of 3.5 was conducted to calculate the number of blastocysts required for biopsy to obtain at least one euploid embryo. CONCLUSIONS: The parental origin of translocation does not significantly affect the PGT-SR outcomes for young balanced translocation carriers. At least 3.5 blastocysts are required to obtain one euploid embryo. Couples should be informed that the probability of obtaining one euploid embryo is low when fewer than 4 blastocysts are obtained in one PGT cycle.
引用
- Tong J, Niu Y, Wan A, et al. Effect of parental origin and predictors for obtaining a euploid embryo in balanced translocation carriers. Reprod Biomed Online. 2021. PMID: 34865999. doi:10.1016/j.rbmo.2021.09.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。